Genesis Technology Group

Genesis Biotechnology Group (GBG) is a privately held consortium of life science companies headquartered in Hamilton, New Jersey. Founded in 1997, the group operates a vertically integrated model that spans the entire drug discovery and diagnostic development spectrum, from initial target identification to clinical laboratory testing. Through its diverse subsidiaries, including Genesis Drug Discovery & Development (GD3) and Medical Diagnostic Laboratories (MDL), GBG provides comprehensive contract research services and specialized molecular diagnostics. The organization focuses on therapeutic areas such as oncology, infectious diseases, and immunology, leveraging its internal research capabilities to develop novel therapeutics and diagnostic tools. GBG's unique structure allows it to support pharmaceutical partners while simultaneously advancing its own internal pipeline of innovative healthcare solutions.